GILD vs NSC · P/E 18, rev $7.80B vs P/E 18, rev $6.46B
Gilead Sciences Inc (GILD) versus Norfolk Southern Corporation (NSC) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Norfolk Southern Corporation (NSC) is a railroads company listed on US.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported NSC revenue for 2026-06-30 was $6.46B. Net income was $1.28B. NSC currently screens at market cap $60.10B and trailing P/E 18.2.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. NSC currently screens at market cap $60.10B and trailing P/E 18.2.
Not investment advice. Open the GILD and NSC stock pages for the full models.
Not investment advice.